AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke

RecruitingNAAges 18 Years - anyAllAnkara Yildirim Beyazıt University
💬

In plain words

What the trial is, and whether it could suit you

Purpose: The primary goal of this study is to investigate how different levels of upper extremity (arm) support affect walking patterns in individuals who have experienced a stroke. Specifically, the research aims to determine how restricting or facilitating arm swing during walking modulates spatiotemporal gait parameters (such as speed, step length, and rhythm). Background: Arm swing plays a crucial role in maintaining balance, stability, and energy efficiency during normal walking. Following a stroke, many patients use walking aids (like canes or walkers) or clinical supports (like parallel bars) that restrict natural arm movement. This study examines whether these restrictions significantly alter gait mechanics in the stroke population. Methodology: Participants will participate in a cross-over experimental trial. Each participant will walk on a specialized treadmill system (C-Mill

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of hemiplegia with ICD-10 code G.81. * Presence of unilateral hemiplegia. * No medical contraindications for the use of assistive devices (e.g., cane, tripod). * Aged 18 years or older. * Ability to walk for at least 2 consecutive minutes. Exclusion Criteria: * Presence of aphasia. * Recurrent stroke. * Montreal Cognitive Assessment (MoCA) score below 10 points.
💊

What it tests

  • C-Mill VR+ (Force-plate integrated treadmill)
  • No Support Protocol
  • Unilateral Support Protocol
  • Bilateral Support Protocol
📍

Where

1 site
Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy